Loading
STP-100 is an experimental antibody-drug conjugate from Stipple Bio, in preclinical development for cancer.
STP-100 is an antibody-drug conjugate from Stipple Bio. An antibody-drug conjugate with a clinically validated linker-payload, built on tumour-specific binders, designed to avoid on-target, off-tumour toxicity. Target and indication are undisclosed. Its furthest stage is preclinical development, for cancer. No clinical trial naming it is registered on ClinicalTrials.gov. Expected to enter clinical studies in early 2027 (company release, 6 April 2026). It has not been shown to work in people.
An antibody-drug conjugate with a clinically validated linker-payload, built on tumour-specific binders, designed to avoid on-target, off-tumour toxicity. Target and indication are undisclosed.
1.STP-100's antibody arm binds its target on the surface of the cancer cell.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"STP-100" OR ABSTRACT:"STP-100") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about STP-100, not a curated reading list.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/